| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.260 | 41.352 | 14.332 | 18.971 | 28.626 | 15.917 | 9.313 | 2.028 | 7.410 | 3.449 |
| Total Income - EUR | 13.260 | 41.352 | 14.332 | 18.993 | 28.626 | 15.917 | 9.313 | 2.028 | 7.410 | 3.449 |
| Total Expenses - EUR | 7.798 | 23.957 | 10.266 | 4.202 | 2.715 | 2.024 | 0 | 0 | 174 | 70 |
| Gross Profit/Loss - EUR | 5.462 | 17.395 | 4.066 | 14.791 | 25.911 | 13.892 | 9.313 | 2.028 | 7.236 | 3.378 |
| Net Profit/Loss - EUR | 5.321 | 14.587 | 3.073 | 14.379 | 24.922 | 13.404 | 9.033 | 1.967 | 6.252 | 2.838 |
| Employees | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Sonimed Innovations Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.342 | 6.193 | 3.382 | 1.328 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 6.665 | 21.979 | 19.766 | 30.528 | 55.191 | 64.323 | 72.210 | 74.462 | 16.143 | 15.481 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.077 | 3.590 | 4.799 | 3.362 | 5.931 | 6.250 | 6.112 | 6.131 | 6.112 | 6.581 |
| Cash | 4.588 | 18.389 | 14.967 | 27.166 | 49.261 | 58.073 | 66.098 | 68.331 | 10.031 | 8.900 |
| Shareholders Funds | 5.366 | 14.630 | 17.455 | 28.498 | 52.868 | 63.171 | 70.804 | 4.076 | 10.316 | 8.070 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.640 | 14.186 | 5.929 | 3.358 | 2.323 | 1.152 | 1.406 | 70.385 | 5.827 | 7.411 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Sonimed Innovations Srl